2025

The paper "Revolutionizing Cancer Immunotherapy: Emerging Nanotechnology-Driven Drug Delivery Systems for Enhanced Therapeutic Efficacy" discusses advancements in cancer immunotherapy, emphasizing nanotechnology's role in improving treatment outcomes. It explores mechanisms like immune checkpoint inhibitors, CAR T-cell therapy, and cancer vaccines, highlighting their potential and limitations. The review underscores nanotechnology-based drug delivery systems' ability to enhance therapeutic specificity, reduce side effects, and overcome biological barriers. It addresses the clinical success of these systems and the importance of regulatory innovations. The paper calls for further research to optimize nanotechnology applications, aiming for personalized cancer treatment solutions.